Liu, Jing
Jiang, Xia
Xu, Binhua
Wang, Guoping
Cui, Nan
Zhang, Xia
Liu, Jingcheng
Mu, Yiming
Guo, Lixin
Clinical trials referenced in this document:
Documents that mention this clinical trial
721-P: Efficacy and Safety of Basal-First Titration Order in Patients with Type 2 Diabetes (T2D) Receiving Short-Term Intensive Insulin Therapy (SIT)
https://doi.org/10.2337/db21-721-p
730-P: Basal Insulin Regimen vs. Twice-Daily Premix Insulin Regimen after Short-Term Intensive Insulin Therapy (SIT) in Patients with Type 2 Diabetes (T2D): A Multicenter, Open-Label Randomized Controlled Trial
https://doi.org/10.2337/db21-730-p
Efficacy and Safety of Basal Insulin-Based Treatment Versus Twice-Daily Premixed Insulin After Short-Term Intensive Insulin Therapy in Patients with Type 2 Diabetes Mellitus in China: Study Protocol for a Randomized Controlled Trial (BEYOND V)
https://doi.org/10.1007/s12325-020-01265-6
Funding for this research was provided by:
Sanofi, China
Article History
Received: 19 December 2019
First Online: 4 March 2020